✦ LIBER ✦

Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma

✍ Scribed by Kazutaka Takagi; Akira Yoshida; Hiromichi Iwasaki; Hitoshi Inoue; Takanori Ueda

Publisher: Springer
Year: 2005
Tongue: English
Weight: 63 KB
Volume: 84
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-005-1050-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response of myasthenia gravis to rituxim

Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma

✍ Ajeet Gajra; Neerja Vajpayee; Sara J. Grethlein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

## Abstract Myasthenia gravis is a B‐cell‐mediated autoimmune neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is an autoantibody‐mediated attack on the acetylcholine receptors (AchRs) at the neuromuscular junction. Rituximab is a genetica

Primary Conjunctival Follicular Lymphoma

Primary Conjunctival Follicular Lymphoma Treated with the Anti-CD20 Antibody Rituximab and Low-Dose Involved-Field Radiotherapy

✍ Masayuki Takahira; Hirokazu Okumura; Hiroshi Minato; Norimasa Urushisaki; Mayumi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 271 KB

Improvement with rituximab in a patient

Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis

✍ Samar Kerkeni; Hubert Marotte; Pierre Miossec 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Successful Treatment With a Chimeric Ant

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

✍ Takahiro Maeda; Yasuaki Yamada; Masayuki Tawara; Reishi Yamasaki; Yuichi Yakata; 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 188 KB

Reduction of tumor burden and stabilizat

Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma

✍ Lucie M. Heinzerling; Margarete Urbanek; Jens O. Funk; Stefan Peker; Oliver Blec 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Chimeric monoclonal anti-CD20 antibody (

Chimeric monoclonal anti-CD20 antibody (rituximab)—an effective treatment for a patient with relapsing hairy cell leukaemia

✍ H Hagberg 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 120 KB